RFK Jr. Pushes Unapproved Peptides as HHS Pauses Enforcement
The Health Secretary is seeking to expand access to peptides the FDA has not approved, while HHS pauses legal action against compounding pharmacies that make certain peptides. Health experts are warning about the lack of human trials and unknown long-term effects.
Robert F. Kennedy Jr., the US Health Secretary and Secretary of Health and Human Services, is seeking to expand access to unapproved peptides. For many voters skeptical of the federal health bureaucracy, this shows a secretary willing to take on the approval gatekeepers.
Kennedy is pushing for pharmacies to produce non-FDA-approved peptides, according to CBS News, and HHS is pausing legal action against compounding pharmacies that make certain peptides. Critics of the administrative state will see a public shift in enforcement.
The pause effectively allows compounding pharmacies to offer the unapproved drugs immediately, according to NBC News, even though the FDA has not approved the peptides. For law-and-order voters, the question is why enforcement is being set aside while the drugs remain unapproved.
Health experts have cautioned against use of the peptides, citing a lack of clinical trials for humans and unknown long-term effects. Adam Yamaguchi took a closer look at the push, according to CBS News.
Original reporting
BBC News
US Health Secretary RFK Jr to expand access to unapproved peptides
Health experts have cautioned against use of the drugs, citing a lack of clinical trials for humans and the unknown long-term effects.
Read the original →CBS News
Inside RFK Jr.'s push for pharmacies to make non-FDA approved peptides
Adam Yamaguchi takes a closer look at Health and Human Services Secretary Robert F. Kennedy Jr.'s push for pharmacies to produce non-FDA approved peptides.
Read the original →NBC News
RFK Jr. takes shortcut to make some unapproved peptides available for use
HHS is pausing legal action against compounding pharmacies that make certain peptides, effectively allowing them to offer the unapproved drugs immediately.
Read the original →
Facts this version was allowed to use
- Robert F. Kennedy Jr. is the US Health Secretary and the Secretary of Health and Human Services.
- Robert F. Kennedy Jr. is seeking to expand access to unapproved peptides.
- Robert F. Kennedy Jr. is pushing for pharmacies to produce non-FDA-approved peptides, according to CBS News.
- HHS is pausing legal action against compounding pharmacies that make certain peptides.
- The pause effectively allows compounding pharmacies to offer the unapproved drugs immediately, according to NBC News.
- The FDA has not approved the peptides.
- Health experts have cautioned against use of the peptides.
- Health experts cited a lack of clinical trials for humans.
- Health experts cited unknown long-term effects.
- Adam Yamaguchi took a closer look at the push, according to CBS News.
Loading comments…
The daily briefing
The day's ten most-covered stories through the lens, every morning, each linked to its original reporting.
Reader comments
Written by readers: not by Lens, its AI or the outlets it credits. Comments are screened before they show. Community rules
Sign in to join the conversation.
No comments yet.